Stockholders’ Equity (Details) - USD ($)											1 Months Ended							12 Months Ended
	Sep. 13, 2022	Aug. 05, 2022	Aug. 01, 2022	Jul. 11, 2022	Aug. 16, 2021	Apr. 05, 2021	Mar. 17, 2021	Mar. 06, 2021	Jan. 05, 2021	Dec. 15, 2020	Dec. 30, 2022	Aug. 30, 2022	Aug. 31, 2021	Jun. 23, 2021	Feb. 23, 2021	Feb. 22, 2021	Feb. 18, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 28, 2022	Jul. 08, 2022	Jul. 22, 2021	Feb. 16, 2021
Stockholders' Equity (Textual)
Common stock, shares authorized																		750,000,000	500,000,000
Common stock, par value (in Dollars per share)																		$ 0.0001	$ 0.0001
Common stock, shares issued																		376,901,679	367,901,679
Common stock, shares outstanding																		376,901,679	367,901,679
Issued shares											3,000,000			60,186,982			60,186,982	2,000,000					2,486,957
Gross proceeds of common stock (in Dollars)							$ 4,550,000							$ 3,009,349			$ 3,009,349		$ (501,100)
Common stock shares							30,333,334
Aggregate shares of common stock							15,166,667	2,426,667
Exercise price (in Dollars per share)	$ 0.04				$ 0.15		$ 0.15	$ 0.1875				$ 0.15	$ 0.15			$ 0.24		$ 0.04		$ 0.0115			$ 0.24
Percentage of Cash Fee								8.00%
Management fee percentage								1.00%
Non-accountable expenses (in Dollars)								$ 35,000
Fees and expenses of legal counsel (in Dollars)								$ 50,000										$ 193,886	221,930
Aggregate number of share percentage								8.00%
Restricted shares						2,000,000				2,500,000
Common stock vested percent						75.00%
Agreement percentage						25.00%
Shares of common stock																						3,650,000
Value of grant date (in Dollars)				$ 110,000														84,000
Agreement fee (in Dollars)			$ 3,000
Grant value (in Dollars)		$ 165,000
Shares Vested										1,000,000
Remaining vested shares										1,500,000
Vested years										2 years
Unvested restricted stock										1,500,000
Expense (in Dollars)																		$ 361,064	$ 301,064
Preferred stock, authorized																		25,000,000	25,000,000
Preferred stock, par value (in Dollars per share)																		$ 0.0001	$ 0.0001
Description of compensation service																		(i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date.
Aggregate shares																		(15,000,000)
Warrant exercisable												3,000,000
Expiration Date												Aug. 30, 2027
Fair value of warrants (in Dollars)												$ 238,182
Purchased shares													10,000,000
Warrant term											5 years
Note amendment transaction description											the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred: ●The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of common stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above;     ● The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.     ● An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.
Warrants outstanding an intrinsic value (in Dollars)																		$ 60,999	$ 0
Shares of Common Stock																							51,901,711
Exercisable period					10 years								10 years			10 years
Options exercisable shares																						208,333
Compensation charge (in Dollars)																$ 6		1
Vesting percentage					50.00%								50.00%
Grant date remaining percentage (in Dollars)					$ 50								$ 50
Option expense (in Dollars)																		$ 1,233,682	1,382,639
Incentive stock options																		155,591,061
Amount of immediate expense (in Dollars)																		$ 31,970
Options exercisable shares	200,000
Intrinsic value outstanding options (in Dollars)																		$ 0	0
Common Stock [Member]
Stockholders' Equity (Textual)
Issued shares																					2,000,000
Gross proceeds of common stock (in Dollars)
Exercise price (in Dollars per share)											$ 0.0115
Shares of common stock																						300,000
Value of grant date (in Dollars)																					$ 84,000
Options exercisable shares	800,000
Warrant [Member]
Stockholders' Equity (Textual)
Exercise price (in Dollars per share)																		$ 0.0345
Unvested restricted stock																		51,000,000	66,302,515
Aggregate shares																		46,521,739
Fair value of warrants (in Dollars)											$ 348,938
Purchased shares											30,000,000
Maximum [Member]
Stockholders' Equity (Textual)
Stock price (in Dollars per share)																$ 0.24
Minimum [Member]
Stockholders' Equity (Textual)
Stock price (in Dollars per share)																$ 0.15
Maximum [Member] | Common Stock [Member]
Stockholders' Equity (Textual)
Shares of Common Stock																		100,000
2021 Stock Incentive Plan [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Shares of Common Stock																		53,000,000
Mr. Corbett [Member]
Stockholders' Equity (Textual)
Option expense (in Dollars)																		$ 266,348
2018 Stock Incentive Plan [Member]
Stockholders' Equity (Textual)
Terminates period																		10 years
2018 Stock Incentive Plan [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Shares of Common Stock																		800,000
2021 Stock Incentive Plan [Member]
Stockholders' Equity (Textual)
Terminates period																		10 years
Richard Rosenblum [Member]
Stockholders' Equity (Textual)
Restricted shares				2,000,000
Option expense (in Dollars)																		$ 111,514	$ 381,006
Samad Harake [Member]
Stockholders' Equity (Textual)
Issued shares		3,000,000
Andrey Novikov [Member]
Stockholders' Equity (Textual)
Purchased shares																208,333
Executive Employment Agreement [Member]
Stockholders' Equity (Textual)
Purchased shares					20,000,000
Executive Employment Agreement [Member] | Warrant [Member]
Stockholders' Equity (Textual)
Purchased shares					20,000,000
Director [Member] | Common Stock [Member]
Stockholders' Equity (Textual)
Shares of common stock																						7,000,000
Chief Financial Officer [Member]
Stockholders' Equity (Textual)
Option expense (in Dollars)																		111,510
Chief Executive Officer [Member]
Stockholders' Equity (Textual)
Incentive stock options				15,000,000
Stock option exercise price (in Dollars per share)				$ 0.15
Amount of immediate expense (in Dollars)																		$ 823,854
Debt Conversion Notices [Member]
Stockholders' Equity (Textual)
Aggregate shares of common stock									61,793,616						61,793,616
Convertible debt amount (in Dollars)									$ 2,259,221						$ 2,259,221
Realizing a loss on conversion (in Dollars)									$ 5,498,820						$ 5,498,820